Both technical and technological advances over the past few years have made laparoscopic splenectomy (LS) more feasible and acceptable. Intraoperative bleeding is the main complication and cause of conversion during LS. Different hemostatic techniques are used for vascular control. In this study, we evaluate LigaSure vessel sealing system as the sole instrument in addition to the lateral approach for achieving a safe vascular control.Eleven patients with hematological disorders of the spleen were enrolled in this 2 year study for LS at Ain Shams University Hospitals. Eight patients had idiopathic thrombocytopenic purpura (ITP), two patients with hereditary spherocytosis and one patient with Evan's syndrome.In all patients the LigaSure vessel sealing system with lateral approach was used to achieve safe vascular control. The patients were 6 females and 5 males, their age ranging between 17-23 years (Median= 20 yrs). The intraoperative blood loss, need for blood transfusion, operative time, post-operative complications and hospital stay as well as the cost were evaluated.Nine cases were successfully performed laparoscopically with two conversions due to hilar bleeding. In all but two patients (converted patients) the intra-operative blood loss was less than 100ml (range 50-100ml) with no need for blood transfusion.The operative time range was 70-100 minutes (median 85 minutes). There were no mortalities in our series. The average hospital stay was 4 days (range 3-5 days), and apart from minor wound infection, no post operative complications were recorded.Stapleless LS using LigaSure vessel sealing system with the lateral approach is a safe procedure to carry out laparoscopic splenectomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.